急性肺血栓栓塞症患者长程抗凝治疗后血栓变化.doc

急性肺血栓栓塞症患者长程抗凝治疗后血栓变化.doc

  1. 1、本文档共7页,可阅读全部内容。
  2. 2、有哪些信誉好的足球投注网站(book118)网站文档一经付费(服务费),不意味着购买了该文档的版权,仅供个人/单位学习、研究之用,不得用于商业用途,未经授权,严禁复制、发行、汇编、翻译或者网络传播等,侵权必究。
  3. 3、本站所有内容均由合作方或网友上传,本站不对文档的完整性、权威性及其观点立场正确性做任何保证或承诺!文档内容仅供研究参考,付费前请自行鉴别。如您付费,意味着您自己接受本站规则且自行承担风险,本站不退款、不进行额外附加服务;查看《如何避免下载的几个坑》。如果您已付费下载过本站文档,您可以点击 这里二次下载
  4. 4、如文档侵犯商业秘密、侵犯著作权、侵犯人身权等,请点击“版权申诉”(推荐),也可以打举报电话:400-050-0827(电话支持时间:9:00-18:30)。
查看更多
急性肺血栓栓塞症患者长程抗凝治疗后血栓变化

急性肺血栓栓塞症患者长程抗凝治疗后血栓变化与D-二聚体的动态改变研究 王艳 张霞 李晶菁 王霆 摘要:目的 探索血浆D-二聚体能否作为反映急性肺血栓栓塞症(APTE)长程抗凝治疗后血栓变化情况的有效监测指标。方法 进行前瞻性、观察性研究,搜集2010年7月至2014年4月在我院经测定D-二聚体及同步CT血管造影(CTPA)明确诊断APTE的患者,共纳入62名,进行长程抗凝治疗,观察血浆D-二聚体变化,随访终点时,患者肺动脉血栓变化以CTPA复查结果作为最终依据。下列情况作为随访终点:①抗凝治疗≥3月,症状缓解,复查D-二聚体降至阴性≥2次,持续时间≥1月;②规范抗凝治疗已≥6月,症状缓解,D-二聚体监测稳定但高于截断值;③患者抗凝治疗≥3月,再次出现腿肿、胸闷等症状。将随访终点D-二聚体检测结果与CTPA结果进行Kappa分析。结果 经规范抗凝治疗,APTE患者血浆D-二聚体均逐步下降;随访终点时,症状无反复、D-二聚体持续阴性者复查CTPA提示肺动脉血栓消失或趋于慢性机化,而症状反复、D-二聚体水平波动增高者复查CTPA证实肺动脉血栓活动复发;Kappa分析提示两种检测方法有一致性,有统计学意义。结论 动态监测血浆D-二聚体可替代CTPA作为APTE抗凝治疗效果的随访指标,具有良好医疗经济学效益,值得推广。 关键词:D-二聚体 急性肺血栓栓塞症 抗凝治疗 CTPA Dynamic Changes in Thrombus and D-dimer in Patients with Acute Pulmonary Thromboembolism Following Long-term Anticoagulant Therapy Wang Yan, Zhang Xia, Li Jingjing, Wang Ting, Department of emergency medicine, Affiliated Hospital of Nantong University, Nantong 226000, Jiangsu, China Corresponding author: Wang Ting, Email: poorot2001@ 【Abstract】: To investigate whether the plasma D-dimer determination is available to reflect the trend of thrombus in long-term anticoagulant therapy of acute pulmoanry thromboembolism (APTE). Methods: For a prospective and observational study, 62 patients diagnosed as APTE by the determination of D-dimer and synchronous CT angiography (CTPA) were collected from July 2010 to April 2014 in our hospital. These patients were treated with regular anticoagulant therapy for at least 3 months with surveillance of plasma D-dimer. At the end of follow-up, the detection of pulmonary thromboembolism by CTPA was used for the final standard of reference. The follow-up survey were defined as: ① anticoagulant therapy for at least 3 months, symptoms relieved, D-dimer levels under cutoff value at least twice and at least last for 1 month; ② anticoagulant therapy for at least 6 months, symptoms relieved, D-dimer level was steady but higher than cutoff value; ③ anticoagulant therapy for at least 3 months, symptoms (such as leg edema and/or dyspnea and so on) reappea

文档评论(0)

ayangjiayu4 + 关注
实名认证
内容提供者

该用户很懒,什么也没介绍

1亿VIP精品文档

相关文档